Abstract
2020 Announcement of Chronic Obstructive Pulmonary Disease Conference
Increasing prevalence of respiratory diseases owing to the growing aging population and increasing pathogens in the environment has been the key factor driving the Chronic Obstructive Pulmonary Disease (COPD) market globally. Pharmaceutical companies have been developing new biobased medications in combination with bio-technology which promises immense growth opportunities along with sustainable development for COPD market over the next decade.
Author(s):
Xiaohong Zhou
Abstract | PDF
Share this
Awards Nomination
Google scholar citation report
Citations : 130
Abstracted/Indexed in
- Google Scholar
- China National Knowledge Infrastructure (CNKI)
- Publons
- Geneva Foundation for Medical Education and Research
- Secret Search Engine Labs
Open Access Journals
- Aquaculture & Veterinary Science
- Chemistry & Chemical Sciences
- Clinical Sciences
- Engineering
- General Science
- Genetics & Molecular Biology
- Health Care & Nursing
- Immunology & Microbiology
- Materials Science
- Mathematics & Physics
- Medical Sciences
- Neurology & Psychiatry
- Oncology & Cancer Science
- Pharmaceutical Sciences